Raymond James Financial Inc. bought a new position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) during ...

Zimmer Biomet's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 4 ...

Zimmer Biomet Holdings, Inc. ZBH is participating in the ongoing American Academy of Orthopaedic Surgeons (AAOS) 2025 Annual Meeting in San Diego, from March 10-14. Here, the company is highlighting ...

Atria Investments Inc boosted its holdings in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 54.0% during ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Zimmer Biomet’s flagship robot, Rosa, is expected to make gains in the near future, CEO Ivan Tornos said at the Barclays 27th Annual Global Healthcare Conference. Mr. Tornos said adoption of the robot ...

Zimmer Biomet CEO Ivan Tornos said he anticipates ASCs to be a major support for growing orthopedic case volumes during the ...

In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report).

Zimmer Biomet (NYSE: ZBH) announced today that it received FDA 510(k) clearance for its Persona Revision SoluTion Femur.

WARSAW, Ind., Feb. 28, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will be presenting at the 27 th Annual ...

Zimmer Biomet CPT ® Hip System implants may put patients at an increased risk of suffering a broken thigh bone near the device. In some cases, patients may even need to undergo corrective surgery. At ...